Skip to Main content Skip to Navigation
Journal articles

Pharmacotherapy of Sexual Addiction

Abstract : Purpose of review: We reviewed recent data on sexual addiction and its treatment. We examined the different definitions of this disorder, related to the pathophysiological mechanisms. We addressed the pharmacological treatment of sexual addiction. Recent findings: Hypersexual behavior can be considered an addictive disorder. Sexual addiction is accompanied by significant psychiatric and addictive comorbidities and is responsible for life impairment. A comprehensive and efficient treatment must be proposed. Selective serotonin reuptake inhibitors seem the first-line pharmacological treatment for sexual addiction. Naltrexone could be another therapeutic option. Psychotherapy and preferentially cognitive-behavioral therapy should be used in association with pharmacotherapy and treatments of comorbidities.
Complete list of metadatas

Cited literature [72 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02881439
Contributor : Clara Martinez Rico <>
Submitted on : Thursday, June 25, 2020 - 4:40:33 PM
Last modification on : Wednesday, August 19, 2020 - 11:58:40 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Citation

Leo Malandain, Jean-Victor Blanc, Florian Ferreri, Florence Thibaut. Pharmacotherapy of Sexual Addiction. Current Psychiatry Reports, Current Medicine Group, 2020, 22 (6), pp.30. ⟨10.1007/s11920-020-01153-4⟩. ⟨inserm-02881439⟩

Share

Metrics

Record views

45